A Global, Postmarketing Observational Safety Study to Evaluate the Safety and Tolerability of Fycompa (Perampanel) as Add-on Therapy in Epilepsy Patients Aged Greater Than or Equal to 12 Years
Clinical trial NCT02033902 · COMPLETED
Trial details
- NCT number
- NCT02033902
- Sponsor
- Eisai Inc.
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2014-06-06
- Primary completion
- 2018-01-31
- Enrollment
- 500
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.